Exact Mass: 305.1216
Exact Mass Matches: 305.1216
Found 171 metabolites which its exact mass value is equals to given mass value 305.1216,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Zaleplon
N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide
Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Zanthodioline
3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-2H,3H,4H,5H,6H-pyrano[3,2-c]quinolin-5-one
Zanthodioline is found in fruits. Zanthodioline is an alkaloid from the bark of Zanthoxylum simulans (Szechuan pepper
Ciprofloxacin-7-ethylenediamine
7-[(2-aminoethyl)amino]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
6-Fluoro-1-methyl-1,4-dihydro-7-(1-piperazinyl)-4-oxoquinoline-3-carboxylic acid
6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
m-Hydroxybenzoylecgonine
8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-[(3-hydroxybenzoyl)oxy]-8-methyl-, (1R,2R,3S,5S)-
p-hydroxybenzoylecgonine
3-(4-hydroxybenzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate
2,2-Diethyl 5-hydroxy-3-phenyl-3,4-dihydro-2H-pyrrole-2,2-dicarboxylic acid
(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
6-[5-(4-Carbamimidoylphenyl)-2-furyl]pyridine-3-carboxamidine
6-[5-(4-carbamimidoylphenyl)furan-2-yl]pyridine-3-carboximidamide
Rohitukine
Rohitukine
A member of the class of chromones that is 4H-chromen-4-one in which the hydrogens at positions 2,5,7 and 8 are replaced by methyl, hydroxy, hydroxy, and (3S,4R)-3-hydroxy-1-methylpiperidin-4-yl groups, respectively. It is an alkaloid initially isolated from Amoora rohituka and is a precursor of the anti-cancer compound flavopiridol.
(2S,4R)-2-Carboxy-4-(E)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt
(2S,4R)-2-Carboxy-4-(E)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt
1,5-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)propyl]-2H-pyrrol-2-one
1,5-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)propyl]-2H-pyrrol-2-one
8-(4-O-methyl-alpha-ribopyranosyloxy)-2-methylquinoline
8-(4-O-methyl-alpha-ribopyranosyloxy)-2-methylquinoline
2,3,5,6,8,9-Hexahydro-1,5,7-triazaspiro[acephenanthrylene-10(7H),1-[2,5]-cyclohexadiene]-6,4-dione
2,3,5,6,8,9-Hexahydro-1,5,7-triazaspiro[acephenanthrylene-10(7H),1-[2,5]-cyclohexadiene]-6,4-dione
Zaleplon
Zaleplon
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CF - Benzodiazepine related drugs D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Desethyleneciprofloxacin
7-(2-aminoethylamino)-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-hydroxybenzoyl)- (9CI)
Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-hydroxybenzoyl)- (9CI)
2-chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide
2-chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide
3-(2-CARBOXY-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER
3-(2-CARBOXY-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER
5-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-4-METHYL-1-(M-TOLYL)-1H-IMIDAZOL-2(3H)-ONE
5-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL)-4-METHYL-1-(M-TOLYL)-1H-IMIDAZOL-2(3H)-ONE
methyl 2-(oxan-4-ylidene)-2-(phenylmethoxycarbonylamino)acetate
methyl 2-(oxan-4-ylidene)-2-(phenylmethoxycarbonylamino)acetate
(3R,4S)-1-tert-Butoxycarbonyl-3-acetoxy-4-phenyl-2-azetidinone
(3R,4S)-1-tert-Butoxycarbonyl-3-acetoxy-4-phenyl-2-azetidinone
benzyl 1-(2-methoxy-2-oxoacetyl)piperidine-2-carboxylate
benzyl 1-(2-methoxy-2-oxoacetyl)piperidine-2-carboxylate
Dribendazole
Dribendazole
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
Ethyl (S)-2-[(S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]-4-phenylbutyrate
Ethyl (S)-2-[(S)-4-methyl-2,5-dioxo-1,3-oxazolidin-3-yl]-4-phenylbutyrate
VU 0357121
VU 0357121
VU 0357121 is a positive and highly selective mGlu5R allosteric modulator (PAM) with an EC50 of 33 nM. VU 0357121 is inactive or very weakly antagonizing at other mGlu receptor subtypes[1].
Tetrahydro-2,2-dimethyl-4,7-methano-6H-1,3-dioxolo[4,5-d][1,2]oxazine-6-carboxylic acid phenylmethyl ester
Tetrahydro-2,2-dimethyl-4,7-methano-6H-1,3-dioxolo[4,5-d][1,2]oxazine-6-carboxylic acid phenylmethyl ester
6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydro-isoquinoline
6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydro-isoquinoline
1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride
1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride
N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-(1,1,2,2,2-pentadeuterioethyl)acetamide
N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-(1,1,2,2,2-pentadeuterioethyl)acetamide
1-Benzyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate
1-Benzyl 3-ethyl 4-oxopiperidine-1,3-dicarboxylate
1-[5-(2-Benzyl-2H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine
1-[5-(2-Benzyl-2H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine
1-[5-(1-Benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine
1-[5-(1-Benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl]methanamine
Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate
Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate
2-({[2-(Methoxycarbonyl)phenyl]amino}carbonyl)cyclohexanecarboxylic acid
2-({[2-(Methoxycarbonyl)phenyl]amino}carbonyl)cyclohexanecarboxylic acid
N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine
N-(2-furanylmethyl)-3-(2-furanylmethylimino)-1-isoindolamine
6-Amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one
6-Amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-G]quinazolin-8-one
(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
(1R,2R,3S,5S)-3-Hydroxy-4-(4-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
(1R,2R,3S,5S)-3-Hydroxy-4-(3-hydroxybenzoyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid
(3s)-3-(1h-Indol-3-Ylmethyl)-3,4-Dihydro-1h-1,4-Benzodiazepine-2,5-Dione
(3s)-3-(1h-Indol-3-Ylmethyl)-3,4-Dihydro-1h-1,4-Benzodiazepine-2,5-Dione
[(E)-(1,3-diphenylpyrazol-4-yl)methylideneamino]urea
[(E)-(1,3-diphenylpyrazol-4-yl)methylideneamino]urea
2-[(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid
2-[(2,3-Dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid
7-Methoxy-2-(3-methoxyanilino)-3-quinolinecarbonitrile
7-Methoxy-2-(3-methoxyanilino)-3-quinolinecarbonitrile
N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-2-methoxyacetamide
N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-2-methoxyacetamide
N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine
N-(3-Ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine
N-(1,3-benzothiazol-2-yl)-2-(2,6-dimethyl-4-morpholinyl)acetamide
N-(1,3-benzothiazol-2-yl)-2-(2,6-dimethyl-4-morpholinyl)acetamide
5-(1,4-Diazepan-1-ylsulfonyl)-4-methylisoquinoline
5-(1,4-Diazepan-1-ylsulfonyl)-4-methylisoquinoline
3-(1,3-Dihydrobenzimidazol-2-ylidene)-1-ethylquinoline-2,4-dione
3-(1,3-Dihydrobenzimidazol-2-ylidene)-1-ethylquinoline-2,4-dione
Thr-Ala-Asp
Thr-Ala-Asp
A tripeptide composed of L-threonine, L-alanine, and L-aspartic acid joined by peptide linkages.
N-(2-furanylmethyl)-1-(phenylmethyl)-4-pyrazolo[3,4-d]pyrimidinamine
N-(2-furanylmethyl)-1-(phenylmethyl)-4-pyrazolo[3,4-d]pyrimidinamine
N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine
N-(2-ethoxyphenyl)-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine
7-(4-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine
7-(4-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine
7-(2-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine
7-(2-Methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine
5-Acetyloxy-2-[[cyclohexyl(oxo)methyl]amino]benzoic acid
5-Acetyloxy-2-[[cyclohexyl(oxo)methyl]amino]benzoic acid
N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide
N-[1-(5,6-dicyano-3-methyl-2-pyrazinyl)ethyl]-N-phenylacetamide
1,3-Dimethyl-6-(1-naphthalenyl)pyrrolo[3,4-d]pyrimidine-2,4-dione
1,3-Dimethyl-6-(1-naphthalenyl)pyrrolo[3,4-d]pyrimidine-2,4-dione
(1-Allyl-1H-benzoimidazol-2-yl)-benzo[1,3]dioxol-5-ylmethylene-amine
(1-Allyl-1H-benzoimidazol-2-yl)-benzo[1,3]dioxol-5-ylmethylene-amine
2-(4-Ethyl-piperazin-1-yl)-5-(5-methyl-furan-2-ylmethylene)-thiazol-4-one
2-(4-Ethyl-piperazin-1-yl)-5-(5-methyl-furan-2-ylmethylene)-thiazol-4-one
2,5-Dimethyl-4-(4-methyl-1-piperidinyl)-6-thieno[2,3-d]pyrimidinecarboxylic acid
2,5-Dimethyl-4-(4-methyl-1-piperidinyl)-6-thieno[2,3-d]pyrimidinecarboxylic acid
N-[2-(1-pyrrolidinyl)ethyl]-8-quinolinesulfonamide
N-[2-(1-pyrrolidinyl)ethyl]-8-quinolinesulfonamide
N-[(E)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]pyridine-4-carboxamide
N-[(E)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]pyridine-4-carboxamide
2-[(2S,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2S,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
N-(2-aminophenyl)-2-anilino-5-pyrimidinecarboxamide
N-(2-aminophenyl)-2-anilino-5-pyrimidinecarboxamide
2-[(2S,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2S,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3S,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2S,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2S,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3S,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2S,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2S,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3R,6S)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3R,6R)-3-benzamido-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
1-[(E)-3-(3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-ylidene)prop-1-enyl]pyrrolidine-2-carboxylic acid
1-[(E)-3-(3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-ylidene)prop-1-enyl]pyrrolidine-2-carboxylic acid
GN44028
GN44028
GN44028 is a potent and orally active hypoxia inducible factor (HIF)-1α inhibitor, with an IC50 of 14 nM. GN44028 inhibits hypoxia-induced HIF-1α transcriptional activity without suppressing HIF-1α mRNA expression, HIF-1α protein accumulation, or HIF-1α/HIF-1β heterodimerization. GN44028 can be used in the research of cancers[1][3].
N-Propargyladenosine
N-Propargyladenosine
N-Propargyladenosine is an adenosine analogue. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. The popular products in this series are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1]. N-Propargyladenosine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
(2e)-3-(6,7-dimethoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one
(2e)-3-(6,7-dimethoxy-2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one
(1s,15r,17r,18s,19r)-17,18-dihydroxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9-trien-12-ium-12-olate
(1s,15r,17r,18s,19r)-17,18-dihydroxy-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9-trien-12-ium-12-olate
(2z)-3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid
(2z)-3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid
1-[2-(4-hydroxyphenyl)ethyl]-5-[(1s,2r)-1,2,3-trihydroxypropyl]pyrrole-2-carbaldehyde
1-[2-(4-hydroxyphenyl)ethyl]-5-[(1s,2r)-1,2,3-trihydroxypropyl]pyrrole-2-carbaldehyde
(1r,13s,16s,17r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol
(1r,13s,16s,17r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-triene-13,16,17-triol
methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate
methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate
2-({2-[(2-amino-1-hydroxypropylidene)amino]-1,4-dihydroxybutylidene}amino)butanedioic acid
2-({2-[(2-amino-1-hydroxypropylidene)amino]-1,4-dihydroxybutylidene}amino)butanedioic acid
(2s,4r)-2-carboxy-4-(e)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt
NA
{"Ingredient_id": "HBIN006744","Ingredient_name": "(2s,4r)-2-carboxy-4-(e)-p-coumaroyloxy-1,1-dimethylpyrrolidinium inner salt","Alias": "NA","Ingredient_formula": "C16H19NO5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3166","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate
methyl 4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate
(3r,4s)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one
(3r,4s)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one
(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-nitropentanedioic acid
(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-nitropentanedioic acid
(3s)-3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol
(3s)-3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol
methyl (3e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate
methyl (3e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-3-enoate
(4r,5r,6e,8e,11r)-4-methyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8,12(16),13-hexaene-3,5,11,14,16-pentol
(4r,5r,6e,8e,11r)-4-methyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8,12(16),13-hexaene-3,5,11,14,16-pentol
3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid
3-methyl-9-oxo-n-(2-sulfoethyl)dec-2-enimidic acid
5,7-dihydroxy-8-[(3r,4s)-3-hydroxy-1-methylpiperidin-4-yl]-2-methylchromen-4-one
5,7-dihydroxy-8-[(3r,4s)-3-hydroxy-1-methylpiperidin-4-yl]-2-methylchromen-4-one
(3s,4r)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one
(3s,4r)-3,4-dihydroxy-7-methoxy-2,2,6-trimethyl-3h,4h-pyrano[3,2-c]quinolin-5-one
3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol
3-(1h-indol-3-ylmethyl)-3h-1,4-benzodiazepine-2,5-diol
5-methoxy-2-[(2-methylquinolin-8-yl)oxy]oxane-3,4-diol
5-methoxy-2-[(2-methylquinolin-8-yl)oxy]oxane-3,4-diol
10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one
10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(12),3,7,9-tetraen-11-one
10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol
10-{[(1e)-2-(4-hydroxyphenyl)ethenyl]amino}-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),2,4(12),7,9-pentaen-11-ol
(2s,3s)-2-amino-3-{[(2e)-3-[2-(3-methyloxiran-2-yl)phenyl]prop-2-enoyl]oxy}butanoic acid
(2s,3s)-2-amino-3-{[(2e)-3-[2-(3-methyloxiran-2-yl)phenyl]prop-2-enoyl]oxy}butanoic acid
methyl 5-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}pyridine-3-carboxylate
methyl 5-{3h,4h,9h-pyrido[3,4-b]indol-1-yl}pyridine-3-carboxylate
3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1,4-dihydroxybutylidene]amino}butanedioic acid
(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1,4-dihydroxybutylidene]amino}butanedioic acid
(1r,6r)-3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
(1r,6r)-3-[3-(3,4-dimethoxyphenyl)propanoyl]-7-oxa-3-azabicyclo[4.1.0]heptan-2-one
1-hydroxy-5-methoxy-6-methyl-7-[(3-methylbut-2-en-1-yl)oxy]-3h-isoindole-4-carboxylic acid
1-hydroxy-5-methoxy-6-methyl-7-[(3-methylbut-2-en-1-yl)oxy]-3h-isoindole-4-carboxylic acid
1-[2-(4-hydroxyphenyl)ethyl]-5-(1,2,3-trihydroxypropyl)pyrrole-2-carbaldehyde
1-[2-(4-hydroxyphenyl)ethyl]-5-(1,2,3-trihydroxypropyl)pyrrole-2-carbaldehyde
methyl (4e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate
methyl (4e)-4-methyl-6-(1,4,6-trihydroxy-3h-isoindol-5-yl)hex-4-enoate
